Image: © MichaelVi/Stock.adobe.com
The Athenry premises is the US multinational’s first European plant and there are plans to fill 1,000 roles.
Dexcom, a US multinational company that develops continuous glucose monitoring (CGM) technologies for managing diabetes, has officially opened a “state-of-the-art” manufacturing facility in Athenry, Co Galway.
The new premises is the organisation’s first manufacturing plant within Europe, the Middle East and Africa (EMEA) and is a significant landmark in the company’s investment into Ireland and the region, it said.
Jake Leach, the president and CEO of Dexcom, said: “The opening of Athenry is an important milestone for Dexcom, establishing our first manufacturing presence in EMEA and reinforcing our long-term commitment to Ireland.
“As we bring Dexcom CGM to more people around the world, expanding our manufacturing capabilities is fundamental to supporting the continued growth of our business.
“With large-scale manufacturing facilities now operating across the US, Europe and Asia-Pacific, we are well positioned to support our ambitious growth plans and Athenry will play a critical role in the next chapter of Dexcom’s global story.”
Construction on the building began in January 2024. Previously, Dexcom stated plans to create more than 1,000 jobs and invest approximately €300m over the course of five years and thus far, almost 500 people have been employed on the site. The remaining roles are expected to be advertised and filled in the coming years.
Taoiseach Micheál Martin, TD said: “The official opening of Dexcom’s Athenry facility is a tremendous vote of confidence in the people and talent of the west of Ireland.
“It is particularly encouraging to see almost 500 people already part of the team, building careers in a world-leading industry and contributing to technologies that make a real difference to people’s lives.
“These are the kinds of high-quality employment opportunities that strengthen communities, attract further investment and help ensure that Galway and the wider region continue to thrive.
“The opening of this facility is an important milestone, not only for Dexcom, but for Athenry and Ireland’s continued success as a global centre for medical technology.”
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.
